Loading...

Neuberger Berman High Yield Strategies Fund

AMEX:NHS
Snowflake Description

Second-rate dividend payer and overvalued.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
NHS
AMEX
$231M
Market Cap
  1. Home
  2. US
  3. Diversified Financials
Company description

Neuberger Berman High Yield Strategies Fund Inc. The last earnings update was 104 days ago. More info.


Add to Portfolio Compare Print
  • Neuberger Berman High Yield Strategies Fund is a fund or ETF! Currently our data availability for these is poor, we only recommend using them as part of a portfolio.
NHS Share Price and Events
7 Day Returns
1.3%
AMEX:NHS
0.1%
US Capital Markets
-0.3%
US Market
1 Year Returns
7.3%
AMEX:NHS
-7.4%
US Capital Markets
7%
US Market
NHS Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Neuberger Berman High Yield Strategies Fund (NHS) 1.3% 4.6% 13.6% 7.3% 9.3% -13.3%
US Capital Markets 0.1% 5% 3.5% -7.4% 53.5% 71.2%
US Market -0.3% 2.2% 8.5% 7% 37.7% 46.8%
1 Year Return vs Industry and Market
  • NHS outperformed the Capital Markets industry which returned -7.4% over the past year.

NHS Value

 Is Neuberger Berman High Yield Strategies Fund undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Neuberger Berman High Yield Strategies Fund. This is due to cash flow or dividend data being unavailable. The share price is $11.83.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Neuberger Berman High Yield Strategies Fund's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Neuberger Berman High Yield Strategies Fund's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
AMEX:NHS PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-10-31) in USD $-0.16
AMEX:NHS Share Price ** AMEX (2019-04-18) in USD $11.83
United States of America Capital Markets Industry PE Ratio Median Figure of 87 Publicly-Listed Capital Markets Companies 30.77x
United States of America Market PE Ratio Median Figure of 3,081 Publicly-Listed Companies 18.17x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Neuberger Berman High Yield Strategies Fund.

AMEX:NHS PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= AMEX:NHS Share Price ÷ EPS (both in USD)

= 11.83 ÷ -0.16

-74.75x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Neuberger Berman High Yield Strategies Fund is loss making, we can't compare its value to the US Capital Markets industry average.
  • Neuberger Berman High Yield Strategies Fund is loss making, we can't compare the value of its earnings to the United States of America market.
Price based on expected Growth
Does Neuberger Berman High Yield Strategies Fund's expected growth come at a high price?
Raw Data
AMEX:NHS PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -74.75x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
United States of America Capital Markets Industry PEG Ratio Median Figure of 34 Publicly-Listed Capital Markets Companies 2.67x
United States of America Market PEG Ratio Median Figure of 2,109 Publicly-Listed Companies 1.56x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Neuberger Berman High Yield Strategies Fund, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Neuberger Berman High Yield Strategies Fund's assets?
Raw Data
AMEX:NHS PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-10-31) in USD $12.45
AMEX:NHS Share Price * AMEX (2019-04-18) in USD $11.83
United States of America Capital Markets Industry PB Ratio Median Figure of 169 Publicly-Listed Capital Markets Companies 6.5x
United States of America Market PB Ratio Median Figure of 5,182 Publicly-Listed Companies 1.91x
AMEX:NHS PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= AMEX:NHS Share Price ÷ Book Value per Share (both in USD)

= 11.83 ÷ 12.45

0.95x

* Primary Listing of Neuberger Berman High Yield Strategies Fund.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Neuberger Berman High Yield Strategies Fund is good value based on assets compared to the US Capital Markets industry average.
X
Value checks
We assess Neuberger Berman High Yield Strategies Fund's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Capital Markets industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Capital Markets industry average (and greater than 0)? (1 check)
  5. Neuberger Berman High Yield Strategies Fund has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

NHS Future Performance

 How is Neuberger Berman High Yield Strategies Fund expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Neuberger Berman High Yield Strategies Fund has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
6.9%
Expected Capital Markets industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Neuberger Berman High Yield Strategies Fund expected to grow at an attractive rate?
  • Unable to compare Neuberger Berman High Yield Strategies Fund's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Neuberger Berman High Yield Strategies Fund's earnings growth to the United States of America market average as no estimate data is available.
  • Unable to compare Neuberger Berman High Yield Strategies Fund's revenue growth to the United States of America market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
AMEX:NHS Future Growth Rates Data Sources
Data Point Source Value (per year)
United States of America Capital Markets Industry Earnings Growth Rate Market Cap Weighted Average 6.9%
United States of America Capital Markets Industry Revenue Growth Rate Market Cap Weighted Average 4.1%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 13.4%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
AMEX:NHS Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (5 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
AMEX:NHS Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2018-10-31 22 16 -3
2018-07-31 23 17 0
2018-04-30 23 17 3
2018-01-31 23 17 14
2017-10-31 23 17 24
2017-07-31 24 18 31
2017-04-30 24 19 39
2017-01-31 24 19 33
2016-10-31 24 19 27
2016-07-31 24 19 7
2016-04-30 24 19 -14
2016-01-31 25 19 -14

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Neuberger Berman High Yield Strategies Fund is high growth as no earnings estimate data is available.
  • Unable to determine if Neuberger Berman High Yield Strategies Fund is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
AMEX:NHS Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (5 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Neuberger Berman High Yield Strategies Fund Company Filings, last reported 5 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

AMEX:NHS Past Financials Data
Date (Data in USD Millions) EPS *
2018-10-31 -0.16
2018-07-31 0.01
2018-04-30 0.18
2018-01-31 0.70
2017-10-31 1.22
2017-07-31 1.60
2017-04-30 1.98
2017-01-31 1.69
2016-10-31 1.40
2016-07-31 0.34
2016-04-30 -0.72
2016-01-31 -0.72

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Neuberger Berman High Yield Strategies Fund will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Neuberger Berman High Yield Strategies Fund's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Neuberger Berman High Yield Strategies Fund has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

NHS Past Performance

  How has Neuberger Berman High Yield Strategies Fund performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Neuberger Berman High Yield Strategies Fund's growth in the last year to its industry (Capital Markets).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Neuberger Berman High Yield Strategies Fund does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Neuberger Berman High Yield Strategies Fund's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Neuberger Berman High Yield Strategies Fund's 1-year growth to the US Capital Markets industry average as it is not currently profitable.
Earnings and Revenue History
Neuberger Berman High Yield Strategies Fund's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Neuberger Berman High Yield Strategies Fund Company Filings, last reported 5 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

AMEX:NHS Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-10-31 22.33 -3.09 2.96
2018-07-31 22.52 0.20 2.99
2018-04-30 22.72 3.49 3.02
2018-01-31 23.09 13.68 3.01
2017-10-31 23.45 23.87 3.01
2017-07-31 23.65 31.25 3.02
2017-04-30 23.85 38.63 3.03
2017-01-31 23.83 32.99 3.00
2016-10-31 23.81 27.36 2.96
2016-07-31 24.08 6.67 2.93
2016-04-30 24.36 -14.02 2.91
2016-01-31 24.80 -14.12 2.97
2015-10-31 25.25 -14.23 3.03
2015-07-31 25.69 -4.76 3.09
2015-04-30 26.13 4.71 3.14
2015-01-31 26.57 10.44 3.17
2014-10-31 27.02 16.16 3.19
2014-07-31 27.04 18.81 3.17
2014-04-30 27.06 21.46 3.15
2014-01-31 27.19 27.54 3.12
2013-10-31 27.33 33.63 3.09
2013-07-31 27.42 41.19 3.02
2013-04-30 27.52 48.76 2.96
2013-01-31 27.52 45.31 2.88
2012-10-31 27.51 41.86 2.80
2012-07-31 28.08 25.70 2.78
2012-04-30 28.66 9.54 2.76

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Neuberger Berman High Yield Strategies Fund has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Neuberger Berman High Yield Strategies Fund has efficiently used its assets last year compared to the US Capital Markets industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Neuberger Berman High Yield Strategies Fund improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Neuberger Berman High Yield Strategies Fund's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Capital Markets industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Neuberger Berman High Yield Strategies Fund has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

NHS Health

 How is Neuberger Berman High Yield Strategies Fund's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Neuberger Berman High Yield Strategies Fund's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Neuberger Berman High Yield Strategies Fund's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • Neuberger Berman High Yield Strategies Fund's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Neuberger Berman High Yield Strategies Fund's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is not covered by short term assets, assets are 0.1x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Neuberger Berman High Yield Strategies Fund Company Filings, last reported 5 months ago.

AMEX:NHS Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-10-31 243.32 124.89 0.02
2018-07-31 243.32 124.89 0.02
2018-04-30 249.67 124.88 0.14
2018-01-31 249.67 124.88 0.14
2017-10-31 262.49 124.87 0.11
2017-07-31 262.49 124.87 0.11
2017-04-30 263.05 124.86
2017-01-31 263.05 124.86
2016-10-31 256.35 125.00 0.84
2016-07-31 256.35 125.00 0.84
2016-04-30 243.03 125.21
2016-01-31 243.03 125.21
2015-10-31 247.76 125.43 0.10
2015-07-31 247.76 125.43 0.10
2015-04-30 275.81 125.92
2015-01-31 275.81 125.92
2014-10-31 281.72 126.59 0.04
2014-07-31 281.72 126.59 0.04
2014-04-30 292.01 127.22 0.12
2014-01-31 292.01 127.22 0.12
2013-10-31 286.66 127.76 0.50
2013-07-31 286.66 127.76 0.50
2013-04-30 318.91 86.03
2013-01-31 318.91 86.03
2012-10-31 301.39 86.37
2012-07-31 301.39 86.37
2012-04-30 290.82 86.02
  • Neuberger Berman High Yield Strategies Fund's level of debt (51.3%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (44.6% vs 51.3% today).
  • Debt is not well covered by operating cash flow (12.8%, less than 20% of total debt).
  • Neuberger Berman High Yield Strategies Fund is making a loss, therefore interest payments are not well covered by earnings.
X
Financial health checks
We assess Neuberger Berman High Yield Strategies Fund's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Neuberger Berman High Yield Strategies Fund has a total score of 0/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

NHS Dividends

 What is Neuberger Berman High Yield Strategies Fund's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
6.88%
Current annual income from Neuberger Berman High Yield Strategies Fund dividends.
If you bought $2,000 of Neuberger Berman High Yield Strategies Fund shares you are expected to receive $138 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Neuberger Berman High Yield Strategies Fund's pays a higher dividend yield than the bottom 25% of dividend payers in United States of America (1.39%).
  • Neuberger Berman High Yield Strategies Fund's dividend is above the markets top 25% of dividend payers in United States of America (3.62%).
Upcoming dividend payment

Purchase Neuberger Berman High Yield Strategies Fund before the 'Buy Limit' to receive their next dividend payment.

Dividends are usually paid every 3 or 6 months, you can time your share purchase to take advantage of upcoming dividend payments.
Dividend payment calendar
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
AMEX:NHS Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
United States of America Capital Markets Industry Average Dividend Yield Market Cap Weighted Average of 43 Stocks 2%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 2009 Stocks 2.4%
United States of America Minimum Threshold Dividend Yield 10th Percentile 0.8%
United States of America Bottom 25% Dividend Yield 25th Percentile 1.4%
United States of America Top 25% Dividend Yield 75th Percentile 3.6%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

AMEX:NHS Past Annualized Dividends Data
Date (Data in $) Dividend per share (annual) Avg. Yield (%)
2019-04-11 0.814 6.928
2019-03-29 0.790 6.865
2019-02-28 0.790 7.015
2019-01-31 0.790 7.147
2018-12-31 0.790 7.696
2018-11-30 0.790 7.942
2018-10-31 0.790 7.642
2018-09-28 0.790 7.425
2018-08-31 0.790 7.224
2018-07-31 0.790 7.232
2018-06-29 0.790 7.286
2018-05-31 0.790 7.232
2018-04-30 0.790 7.179
2018-03-29 0.790 7.140
2018-02-01 0.870 7.758
2017-11-30 0.870 7.445
2017-10-31 0.870 7.371
2017-09-29 0.870 7.164
2017-08-31 0.870 7.237
2017-07-31 0.870 7.272
2017-06-30 0.870 7.311
2017-05-31 0.870 7.323
2017-05-01 0.870 7.249
2017-03-31 0.870 7.298
2017-03-01 0.960 8.144
2017-01-31 0.960 8.006
2016-12-30 0.960 8.107
2016-11-30 0.960 8.312
2016-10-31 0.960 8.517
2016-09-30 0.960 8.146
2016-08-31 0.960 8.227
2016-07-29 0.960 8.283
2016-06-30 0.960 8.530
2016-05-31 0.960 8.797
2016-04-29 0.960 8.981
2016-04-01 0.960 9.013
2016-02-29 0.960 9.174
2016-01-29 0.960 9.994
2015-12-31 0.960 9.895
2015-11-30 0.960 9.668
2015-10-30 0.960 9.251
2015-09-30 0.960 9.142
2015-08-31 0.960 9.053
2015-07-31 0.960 8.862
2015-06-30 0.960 8.381
2015-05-29 0.960 8.001
2015-04-30 0.960 7.783
2015-04-01 0.960 7.658
2015-02-27 1.080 8.634
2015-01-30 1.080 8.589
2014-12-31 1.080 8.800
2014-11-28 1.080 8.861
2014-10-31 1.080 8.389
2014-09-30 1.080 8.362
2014-08-29 1.080 8.177
2014-07-31 1.080 8.088
2014-07-01 1.080 7.930
2014-05-30 1.080 7.839
2014-05-02 1.080 7.850
2014-03-31 1.080 7.885
2014-03-03 1.080 7.880
2014-01-31 1.080 7.978
2013-12-31 1.080 8.058
2013-11-29 1.080 8.161
2013-10-31 1.080 8.125
2013-09-30 1.080 8.218
2013-08-30 1.080 8.391
2013-07-31 1.080 8.439
2013-06-28 1.080 8.334
2013-05-31 1.080 8.250
2013-04-30 1.080 7.620
2013-03-28 1.080 7.636
2013-02-28 1.080 7.687
2013-01-31 1.080 7.725
2012-12-31 1.080 7.651
2012-09-28 1.080 7.691
2012-08-31 1.080 7.260
2012-07-31 1.080 7.333
2012-06-29 1.080 7.523
2012-05-31 1.080 7.865
2012-04-30 1.080 7.884
2012-03-30 1.080 7.918
2012-02-29 1.080 7.820
2012-01-31 1.200 8.469
2011-12-30 1.200 8.712
2011-11-30 1.200 9.164
2011-10-31 1.200 9.320
2011-09-30 1.200 9.321
2011-08-31 1.200 9.189
2011-07-29 1.200 9.417
2011-06-30 1.200 8.575
2011-05-31 1.320 9.120
2011-04-29 1.320 8.858
2011-03-31 1.320 9.111
2011-02-28 1.320 9.223
2011-01-31 1.320 9.071
2010-12-31 1.320 9.493
2010-11-30 1.320 9.901
2010-10-29 1.320 9.583
2010-09-30 1.320 9.283
2010-08-31 1.320 9.792
2010-08-09 1.320 9.972
2010-06-30 1.320 9.934
2010-06-01 1.320 10.375
2010-04-30 1.320 10.675
2010-03-31 1.320 9.761
2010-02-26 1.320 10.146
2010-01-29 1.320 10.795
2009-12-31 1.020 8.437
2009-11-30 1.020 8.788
2009-10-30 1.020 9.194
2009-09-30 1.020 8.966
2009-08-31 1.020 9.286
2009-07-31 1.020 9.846
2009-07-01 1.020 10.824
2009-05-29 1.020 10.834
2009-04-30 1.020 11.577
2009-04-22 1.020 12.898

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Dividends per share have been stable in the past 10 years.
  • Dividends per share have fallen over the past 10 years.
Current Payout to shareholders
What portion of Neuberger Berman High Yield Strategies Fund's earnings are paid to the shareholders as a dividend.
  • The company is paying a dividend however it is incurring a loss.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Neuberger Berman High Yield Strategies Fund's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Neuberger Berman High Yield Strategies Fund afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Neuberger Berman High Yield Strategies Fund has a total score of 3/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

NHS Management

 What is the CEO of Neuberger Berman High Yield Strategies Fund's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Robert Conti
COMPENSATION $0
AGE 62
CEO Bio

Mr. Robert John Conti, also known as Bobby, has been the Chief Executive Officer and President of Neuberger Berman BD LLC since 2008. Mr. Conti has been a Managing Director at Neuberger Berman LLC since 2007. He serves as President and Chief Executive Officer of various funds in the fund complex of Neuberger Berman Funds. He has been an Employee of Neuberger Berman since 1980. He served as Vice President at General Electric Capital Corp. since 2004. Mr. Conti served as a Controller of NB Management until 1996, Investment Manager since 2002, Administrator since 2003 and Treasurer from 1996 to 1999. He served as a Senior Vice President at Neuberger Berman from 2003 to 2006 and Vice President from 1999 to 2003. He served as Vice President of sixteen registered investment companies for which NB Management acts as investment manager and administrator and Vice President of one registered investment company for which NB Management acts as investment adviser since 2006. He served as Chief Executive Officer, President, Trustee and Member of Executive Committee at Neuberger Berman Advisers Management Trust - Small Cap Growth Portfolio. Mr. Conti served a variety of positions in connection with Neuberger Berman's mutual funds business. He served as an Executive Vice President at Neuberger Berman's mutual funds. He serves as a Director and Trustee of 53 funds in the fund complex of Neuberger Berman Funds. He has been the Chairman of the Board of Staten Island Mental Health Society since 2008.

CEO Compensation
  • Insufficient data for Robert to compare compensation growth.
  • Insufficient data for Robert to establish whether their remuneration is reasonable compared to companies of similar size in United States of America.
Management Team

Robert Conti

TITLE
Chief Executive Officer
AGE
62

Joe Amato

TITLE
Director
AGE
56

John McGovern

TITLE
Principal Financial Officer
AGE
48

Chamaine Williams

TITLE
Chief Compliance Officer
AGE
47

Andrew Allard

TITLE
Chief Legal Officer and Anti-Money Laundering Compliance Officer
AGE
57

Claudia Brandon

TITLE
Executive Vice President and Secretary
AGE
62

Brian Kerrane

TITLE
Vice President
AGE
49

Owen McEntee

TITLE
Vice President
AGE
57

Agnes Diaz

TITLE
Vice President
AGE
47

Frank Rosato

TITLE
Assistant Treasurer
AGE
47
Board of Directors Tenure

Average tenure and age of the Neuberger Berman High Yield Strategies Fund board of directors in years:

12.3
Average Tenure
69
Average Age
  • The average tenure for the Neuberger Berman High Yield Strategies Fund board of directors is over 10 years, this suggests they are a seasoned and experienced board.
Board of Directors

Tom Seip

TITLE
Non-Executive Chairman
COMPENSATION
$21K
AGE
68
TENURE
10.3 yrs

Robert Conti

TITLE
Chief Executive Officer
AGE
62
TENURE
11.3 yrs

Joe Amato

TITLE
Director
AGE
56
TENURE
10.3 yrs

George Morriss

TITLE
Independent Director
COMPENSATION
$18K
AGE
71
TENURE
12.3 yrs

Michael Knetter

TITLE
Independent Director
COMPENSATION
$18K
AGE
58
TENURE
12.3 yrs

Candace Straight

TITLE
Independent Director
COMPENSATION
$18K
AGE
70
TENURE
13 yrs

Faith Colish

TITLE
Independent Director
COMPENSATION
$18K
AGE
83
TENURE
13 yrs

Martha Goss

TITLE
Independent Director
COMPENSATION
$16K
AGE
68
TENURE
11.8 yrs

Peter Trapp

TITLE
Independent Director
COMPENSATION
$18K
AGE
74
TENURE
13 yrs

Howard Mileaf

TITLE
Independent Director
COMPENSATION
$17K
AGE
81
TENURE
13 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
12. Apr 19 Buy Saba Capital Management, L.P. Company 10. Apr 19 11. Apr 19 121,750 $11.68 $1,416,517
11. Apr 19 Buy Saba Capital Management, L.P. Company 10. Apr 19 10. Apr 19 92,046 $11.62 $1,069,575
10. Apr 19 Buy Saba Capital Management, L.P. Company 08. Apr 19 09. Apr 19 132,636 $11.58 $1,532,418
08. Apr 19 Buy Saba Capital Management, L.P. Company 03. Apr 19 05. Apr 19 94,645 $11.55 $1,090,438
03. Apr 19 Buy Saba Capital Management, L.P. Company 02. Apr 19 02. Apr 19 9,620 $11.37 $109,379
01. Apr 19 Buy Saba Capital Management, L.P. Company 28. Mar 19 29. Mar 19 18,298 $11.31 $206,909
28. Mar 19 Buy Saba Capital Management, L.P. Company 26. Mar 19 27. Mar 19 11,769 $11.29 $132,783
25. Mar 19 Buy Saba Capital Management, L.P. Company 21. Mar 19 22. Mar 19 19,479 $11.34 $220,849
21. Mar 19 Buy Saba Capital Management, L.P. Company 19. Mar 19 20. Mar 19 49,193 $11.28 $553,021
19. Mar 19 Buy Saba Capital Management, L.P. Company 18. Mar 19 18. Mar 19 7,750 $11.21 $86,878
01. Mar 19 Buy Saba Capital Management, L.P. Company 14. Jan 19 18. Jan 19 269,165 $10.40 $2,774,983
22. Feb 19 Buy Saba Capital Management, L.P. Company 20. Feb 19 21. Feb 19 42,245 $11.11 $468,627
20. Feb 19 Buy Saba Capital Management, L.P. Company 15. Feb 19 19. Feb 19 59,831 $11.03 $659,936
13. Feb 19 Buy Saba Capital Management, L.P. Company 11. Feb 19 11. Feb 19 20,503 $10.96 $224,713
11. Feb 19 Buy Saba Capital Management, L.P. Company 06. Feb 19 08. Feb 19 97,379 $10.93 $1,063,020
06. Feb 19 Buy Saba Capital Management, L.P. Company 04. Feb 19 05. Feb 19 192,631 $10.86 $2,079,460
04. Feb 19 Buy Saba Capital Management, L.P. Company 30. Jan 19 01. Feb 19 384,409 $10.76 $4,105,206
30. Jan 19 Buy Saba Capital Management, L.P. Company 28. Jan 19 29. Jan 19 116,200 $10.52 $1,221,615
28. Jan 19 Buy Saba Capital Management, L.P. Company 24. Jan 19 25. Jan 19 205,163 $10.46 $2,142,820
24. Jan 19 Buy Saba Capital Management, L.P. Company 22. Jan 19 23. Jan 19 204,332 $10.40 $2,122,490
05. Jan 19 Buy Indian Hill Llc Company 02. Jan 19 02. Jan 19 850 $9.60 $8,158
05. Jan 19 Buy Bradley Tank Individual 02. Jan 19 02. Jan 19 1,150 $9.60 $11,038
29. Dec 18 Buy Indian Hill Ii Llc Company 26. Dec 18 28. Dec 18 16,200 $9.59 $155,236
29. Dec 18 Buy Bradley Tank Individual 26. Dec 18 28. Dec 18 22,667 $9.59 $217,206
29. Dec 18 Buy Joseph Lind Individual 27. Dec 18 27. Dec 18 10,000 $9.63 $96,339
04. Dec 18 Buy Indian Hill Ii Llc Company 30. Nov 18 30. Nov 18 9,766 $10.27 $100,285
04. Dec 18 Buy Bradley Tank Individual 30. Nov 18 30. Nov 18 9,766 $10.27 $100,285
X
Management checks
We assess Neuberger Berman High Yield Strategies Fund's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Neuberger Berman High Yield Strategies Fund has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

NHS News

Simply Wall St News

NHS Company Info

Description

Neuberger Berman High Yield Strategies Fund Inc. is a closed-ended fixed income mutual fund launched by Neuberger Berman LLC. The fund is managed by Neuberger Berman Investment Advisers LLC. It invests in fixed income markets across the globe. The fund typically invests in high yield debt securities of various sectors, such as auto parts and equipment, airlines, automotive, electronics, health services, packaging, telecom-integrated/services, gaming, and gas distribution. It was formerly known as Neuberger Berman High Yield Strategies Fund. Neuberger Berman High Yield Strategies Fund Inc. was formed on July 28, 2003 and is domiciled in the United States.

Details
Name: Neuberger Berman High Yield Strategies Fund Inc.
NHS
Exchange: AMEX
Founded: 2003
$231,165,120
19,540,585
Website: http://www.nb.com/Pages/Public/en-us/Products/high-yield-strategies-fund.aspx
Address: Neuberger Berman High Yield Strategies Fund Inc.
1290 Avenue of the Americas,
New York City,
New York, 10104,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
AMEX NHS Common Shares NYSE MKT LLC US USD 29. Jul 2003
Number of employees
Current staff
Staff numbers
0
Neuberger Berman High Yield Strategies Fund employees.
Industry
Asset Management and Custody Banks
Diversified Financials
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/21 00:16
End of day share price update: 2019/04/18 00:00
Last earnings filing: 2019/01/07
Last earnings reported: 2018/10/31
Last annual earnings reported: 2018/10/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.